Researchers from the University of Liverpool’s Centre for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, ...
Both neutralizing antibodies and antibody effector functions are needed for protection against re-infection with respiratory syncytial virus (RSV), which may explain why it has been challenging to ...
Drugmaker Johnson + Johnson said Monday it has paused the advanced clinical trial of its experimental coronavirus vaccine because of an unexplained illness in one of the volunteers. "Following our ...
Researchers from the University of Liverpool's Centre for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, ...
MEXICO CITY, Nov 10 (Reuters) - Johnson & Johnson's (JNJ.N), opens new tab Janssen unit has received the green light to carry out late stage trials for its coronavirus vaccine in Mexico, Foreign ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results